Integrated Featuresfor Process Intensification

摘要

Biopharmaceutical companies are facing major challenges today, including rising drug-manufacturing costs and lower production volumes related to unpredictable demands. To achieve the necessary reductions in both costs of goods (CoG) and infrastructureand operational costs, biopharmaceutical manufacturers integrate process intensification strategies into their production schemes.